The brain-gut interaction: The conversation and the implications

South African Journal of Clinical Nutrition

Volumn 24, Issue 3 SUPPL. 1, 2011, Pages 8-14

  Prins, Arina ^a  

^a Little Company of Mary Medical Centre   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; GASTRIN; NEUROPEPTIDE; NEUROTRANSMITTER; SECRETIN; SEROTONIN;

ARTICLE; AUTONOMIC NERVOUS SYSTEM; BRAIN FUNCTION; BRAIN INTESTINE INTERACTION; CENTRAL NERVOUS SYSTEM; CHEMOSENSITIVITY; DIGESTIVE SYSTEM FUNCTION DISORDER; ENTERITIS; ENTEROENTERIC REFLEX; GASTROINTESTINAL MOTILITY DISORDER; GLUCOSE HOMEOSTASIS; HUMAN; HYPERSENSITIVITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; INFLAMMATORY DISEASE; INTESTINE FLORA; INTESTINE FUNCTION; INTESTINE INNERVATION; MAST CELL; MECHANOSENSITIVITY; MENTAL STRESS; NERVE CELL NETWORK; NEUROIMMUNOLOGY; NEUROMODULATION; OBESITY; PHYSICAL SENSITIVITY; REFLEX; SATIETY; SENSORY NERVE; SENSORY STIMULATION; SIGNAL TRANSDUCTION; VISCERAL HYPERSENSITIVITY; VISCERAL PAIN;

EID: 80055041060     PISSN: 16070658     EISSN: None     Source Type: Journal    
DOI: 10.1080/16070658.2011.11734373     Document Type: Article

References (40)

1. Liao D, Lelic D, Gao F, Drewes AM, Gregersen H. Biomechanical functional and sensory modelling of the gastrointestinal tract. Philos Transact A Math Phys Eng Sci. 2008. 366(1879): 3281-3299.
2. Wood JD, Alpers DH, Andrews PL. Fundamentals of neurogastroenterology. Gut. 1999. 45. Suppl 2: II6-II16.
3. Mayer EA, Tillisch K, Bradesi S. Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease. Aliment Pharmacol Ther. 2006. 24(6): 919-33.
4. Gaman A, Kuo B. Neuromodulatory processes of the brain-gut axis. Neuromodulation. 2008. 11(4): 249-259.
5. Bolen BB. The Brain Gut Connection in Irritable Bowel Syndrome. The Brain Gut Connection in Irritable Bowel Syndrome. About.com Guide. 2011. Available from http://ibs.about.com/od/symptomsofib1/a/ braingut.htm.
6. Nervous system. Wikipedia. Available from http:/en.wikipedia.org/wiki/Nervous system.
7. Baker DE. Rationale for using serotonergic agents to treat irritable bowel syndrome. Am J Health Syst Pharm. 2005 Apr 1;62(7):700-11.
8. fmedscape.com/viewarticle Akbar A, Walters JRF, Ghosh S. Visceral hypersensitivity in irritable bowel syndrome: molecular mechanisms and therapeutic agents. Pharmacology and therapeutics 2009. 30(5): 423-435, http:// www.medscape.com/viewarticle/707273.
9. Grundy D. Neuroanatomy of visceral nociception: vagal and splanchnic afferent. Gut. 2002. 51(Suppl 1): i2 - i5.
10. Gershon MD. Nerves, reflexes, and the enteric nervous system. J. Clin. Gastroenterol. 2005. 38: S184 - S193.
11. Goyal RK, Hirano I. The enteric nervous system. N Engl J Med. 1996. 334(17): 1106-1115.
12. Furness JB. Enteric nervous system. Scholarpedia. 2007. 2(10):4064. Available from http://www. scholarpedia.org/article/Enteric_nervous_system.
13. Barajon I, Serrao G, Arnaboldi F, Opizzi E, Ripamonti G, Balsari A, Rumio C. Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia. J Histochem Cytochem. 2009. 57(11):1013-23.
14. Chang L and Harris LA. Pathophysiology of IBS and serotonin signaling. Medscape. 2004. Available on http://www.medscape.org/viewarticle/463521_3.
15. Mawe GM, Coates MD and Moses PL. Review article: intestinal serotonin signalling in irritable bowel. Syndrome. Aliment Pharmacol Ther 23, 1067-1076.
16. Tougas G, Gershon MD, Olden KW, Peterson WL, Talley NJ, Integrating Current Concepts of Causality: Towards a Unifying Hypothesis. Medscape. 2002. http://www.medscape.org/viewarticle/439588_2.
17. De Giorgio R, Camilleri M (2004) Human enteric neuropathies: morphology and molecular pathology. Neurogastroenterol. Motil. 16: 515-531.
18. Lomax AE, Linden DR, Mawe GM, Sharkey KA (2006) Effects of gastrointestinal inflammation on enteroendocrine cells and enteric neural reflex circuits. Autonom. Neurosci. 126: 250-257.
19. Bielefeldt K. Overview: Neuromuscular Physiology of the. Gastrointestinal Tract. Available on http:// www.mpoullis.net/bsosc/Overview%20of%20Neuromuscular%20Physiology%20in%20GI%20 notes.doc.
20. Grundy D. What activates visceral afferents? Gut. 2004. 53, Suppl 2: 5-8.
21. Cash BD. Neuromuscular Dysfunction and IBS: Clinical Implications. 2006. http://www.medscape.org/ viewarticle/548600.
22. Bandlapalli P, Banji D, Banji OJF, Swetha D and Pratusha NG. Role of stress in pathophysiology of irritable bowel syndrome. IRJP. 2011. 2(5): 54-60.
23. Kellow JE, Azpiroz F, Delvaux M, Gebhart GF, Mertz HR, Quigley EM, Smout AJ. Applied principles of neurogastroenterology: physiology/motility sensation. Gastroenterology. 2006. 130(5): 1412-1420.
24. Taché Y, Martinez V, Million M, Wang L. Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: role of brain corticotropin-releasing factor receptors. Am J Physiol Gastrointest Liver Physiol. 2001. 280(2): 173-177.
25. Posserud I, Ersryd A and Simrén. Functional findings in irritable bowel syndrome. 2006. Functional findings in irritable bowel syndrome.
26. Quigley EM. Changing face of irritable bowel syndrome. World J Gastroenterol. 2006. 12(1): 1-5.
27. Kyrlagkitsis I and Karamanolis DG. Pathophysiology of irritable bowel syndrome. The role of brain-gut axis and serotinergic receptors. 2002: Annals of Gastroenterology. 2002. 15(3): 248-252.
28. Tillisch K, Mayer EA, Labus JS. Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome. Gastroenterology. 2011. 40(1): 91-100.
29. Rodríguez-Fandiño O, Hernández-Ruiz J, Schmulson M. From cytokines to toll-like receptors and beyond - current knowledge and future research needs in irritable bowel syndrome. J Neurogastroenterol Motil. 2010. 6(4): 363-373.
30. Tanaka Y, Kanazawa M, Fukudo S, Drossman DA. Biopsychosocial model of irritable bowel syndrome. J Neurogastroenterol Motil. 2011. 17(2): 131-139.
31. Salzmann JL, Peltier-Koch F, Bloch F, Petite JP, Camilleri JP: Morphometric study of colonic biopsies: a new method of estimating inflammatory diseases. Lab invest. 1989. 60:847-851.
32. Philpott H, Gibson P, Thien F. Irritable bowel syndrome - An inflammatory disease involving mast cells. Asia Pac Allergy. 2011. 1(1):36-42. Available from http://dx.doi.org/10.5415/apallergy.2011.1.1.36.
33. Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, Pasquinelli G, Morselli-Labate AM, Grady EF, Bunnett NW, Collins SM, Corinaldesi R. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693-702.
34. Zhao RH, Baig MK, Mack J, Abramson S, Woodhouse S, Wexner SD. Altered serotonin immunoreactivities in the left colon of patients with colonic inertia. Colorectal Dis. 2002. 4(1):56-60.
35. Zhao R, Baig MK, Wexner SD, Chen W, Singh JJ, Nogueras JJ, Woodhouse S. Enterochromaffin and serotonin cells are abnormal for patients with colonic inertia. Dis Colon Rectum. 2000. 43(6):858-863
36. El-Salhy M, Norrgård O, Spinnell S. Abnormal colonic endocrine cells in patients with chronic idiopathic slow-transit constipation. Scand J Gastroenterol. 1999 Oct;34(10):1007-11
37. Miwa J, Echizen H, Matsueda K, Umeda N. Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits. Digestion. 2001;63(3):188-94.
38. Lee BJ, Bak YT. Irritable bowel syndrome, gut microbiota and probiotics. J Neurogastroenterol Motil. 2011 Jul;17(3):252-66.
39. Phillips ML. Gut Reaction: Environmental Effects on the Human Microbiota. Environmental Health Perspectives. 2009;117(5):A198-A205.
40. Ghoshal UC, Park H, Gwee K-A. Bugs and Irritable Bowel Syndrome: The Good, the Bad and the Ugly. J Gastroenterol Hepatol. 2010. 25(2):244-251.